Skip to content
Home » ​Did The ‘Fatty Bubble’ Pop? Eli Lilly Discounts Low-Dose Zepbound Vials By 50% – Tyler Durden

​Did The ‘Fatty Bubble’ Pop? Eli Lilly Discounts Low-Dose Zepbound Vials By 50% – Tyler Durden

  • by
​Did The ‘Fatty Bubble’ Pop? Eli Lilly Discounts Low-Dose Zepbound Vials By 50% – Tyler Durden

Did The ‘Fatty Bubble’ Pop? Eli Lilly Discounts Low-Dose Zepbound Vials By 50% This morning, the spotlight has shined brightly on the GLP-1 complex after Eli Lilly & Co. announced that its new weight-loss drug, Zepbound, in single-low-dose vials, will be priced at a 50% or greater discount compared to the retail prices of other GLP-1s for obesity. Companies exposed to GLP-1s are lower on the news in premarket trading in New York, with Wall Street analysts speculating whether this steep discount signals that the ‘fatty bubble’ has burst…  Eli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients…  — Continue at ZeroHedge News : Read More